Home/Filings/4/0001562180-24-008100
4//SEC Filing

Blackley Richard Scott 4

Accession 0001562180-24-008100

CIK 0001568651other

Filed

Dec 2, 7:00 PM ET

Accepted

Dec 3, 4:15 PM ET

Size

19.1 KB

Accession

0001562180-24-008100

Insider Transaction Report

Form 4
Period: 2024-12-01
Blackley Richard Scott
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2024-12-01+37,577898,467 total
  • Exercise/Conversion

    Class A Common Stock

    2024-12-01+7,015860,890 total
  • Exercise/Conversion

    Class A Common Stock

    2024-12-01+8,653907,120 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-018,65377,872 total
    Class A Common Stock (8,653 underlying)
  • Sale

    Class A Common Stock

    2024-12-02$18.07/sh24,823$448,552882,297 total
  • Sale

    Class A Common Stock

    2024-12-02$18.48/sh456$8,427881,841 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-017,01521,048 total
    Class A Common Stock (7,015 underlying)
  • Exercise/Conversion

    Restricted Stock Units

    2024-12-0137,577338,200 total
    Class A Common Stock (37,577 underlying)
Footnotes (7)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
  • [F2]The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into prior to February 27, 2023 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.46 to $18.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.46 to $18.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
  • [F5]The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.
  • [F6]The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2023.
  • [F7]The restricted stock units vest in twelve equal quarterly installments beginning on June 1, 2024.

Issuer

Oscar Health, Inc.

CIK 0001568651

Entity typeother

Related Parties

1
  • filerCIK 0001525020

Filing Metadata

Form type
4
Filed
Dec 2, 7:00 PM ET
Accepted
Dec 3, 4:15 PM ET
Size
19.1 KB